Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States. Its product candidates are Avutometinib, which is an orally administered, small molecule dual RAF/MEK inhibitor developed to block MEK...
103 insider purchases on record · latest filing 2024-01-24.
Insiders have also filed 163 sale transactions at VSTM.